CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-16 | Tingley Whittemore Chief Medical Officer | Sale | −1,625 | $2.89 | $5K | 107,106 |
| 2024-08-16 | Ali Faraz Chief Executive Officer | Sale | −5,802 | $2.89 | $17K | 192,277 |
| 2024-08-16 | Ali Faraz Chief Executive Officer | Sale | −3,946 | $2.89 | $11K | 188,331 |
| 2024-08-15 | Saito Chihiro SVP, Accounting and Fin. Ops. | Grant or award | +25,000 | 65,604 | ||
| 2024-03-05 | Hoey Timothy Chief Scientific Officer | Sale 10b5-1 | −3,300 | $7.00 | $23K | 245,346 |
| 2024-02-23 | Hoey Timothy Chief Scientific Officer | Grant or award | +12,500 | 248,646 | ||
| 2024-02-23 | Hoey Timothy Chief Scientific Officer | Grant or award · Stock Option (Right to buy) | +75,000 | 75,000 | ||
| 2024-02-23 | Tingley Whittemore Chief Medical Officer | Grant or award | +35,000 | 108,534 | ||
| 2024-02-23 | Tingley Whittemore Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +215,000 | 215,000 | ||
| 2024-02-23 | PATTERSON LEONE D Chief Fin. and Bus. Officer | Grant or award | +35,000 | 95,755 | ||
| 2024-02-23 | PATTERSON LEONE D Chief Fin. and Bus. Officer | Grant or award · Stock Option (Right to buy) | +205,000 | 205,000 | ||
| 2024-02-23 | Ali Faraz Chief Executive Officer | Grant or award | +85,000 | 198,079 | ||
| 2024-02-23 | Ali Faraz Chief Executive Officer | Grant or award · Stock Option (Right to buy) | +505,000 | 505,000 | ||
| 2024-02-20 | Hoey Timothy Chief Scientific Officer | Sale 10b5-1 | −6,369 | $5.31 | $34K | 236,346 |
| 2024-02-20 | Hoey Timothy Chief Scientific Officer | Sale 10b5-1 | −200 | $6.17 | $1K | 236,146 |
| 2024-02-16 | Hoey Timothy Chief Scientific Officer | Sale | −4,681 | $5.86 | $27K | 242,715 |
| 2024-02-16 | Tingley Whittemore Chief Medical Officer | Sale | −6,500 | $5.86 | $38K | 73,534 |
| 2024-02-16 | PATTERSON LEONE D Chief Fin. and Bus. Officer | Sale | −5,201 | $5.86 | $30K | 60,755 |
| 2024-02-16 | Ali Faraz Chief Executive Officer | Sale | −6,358 | $5.86 | $37K | 113,079 |
| 2024-02-12 | COLUMN GROUP III GP, LP 10% owner | Purchase | +2,222,222 | $4.50 | $10.0M | 13,599,275 |
Page 7 of 12 · 228 trades